Briedigkeit L, Ulmer M, Göbel U, Natusch R, Reinhold-Keller E, Gross W L
Berlin-Buch Clinical Center, 1st Medical Department, Germany.
Adv Exp Med Biol. 1993;336:491-5.
Treatment and outcome of 111 patients who fell ill with Wegener's granulomatosis (WG) between 1966 and 1990 were analysed retrospectively. Two regimens of treatment were distinguished: "conventional" treatment, i.e. daily application of cyclophosphamide/corticosteroids (FAUCI scheme) or azathioprine/corticosteroids or corticosteroids alone, and "stage-adapted" treatment, characterized by change of different treatments (e.g. cyclophosphamide pulse therapy, cotrimoxazole) according to the extent and activity of disease. In patients who received stage-adapted treatment, exacerbations occurred significantly more frequent than in conventionally treated patients, while lethal outcome was much more frequent in conventionally treated patients.
对1966年至1990年间罹患韦格纳肉芽肿(WG)的111例患者的治疗及转归进行了回顾性分析。区分了两种治疗方案:“传统”治疗,即每日应用环磷酰胺/皮质类固醇(FAUCI方案)或硫唑嘌呤/皮质类固醇或仅用皮质类固醇,以及“根据病情阶段调整的”治疗,其特点是根据疾病的程度和活动度改变不同的治疗方法(如环磷酰胺冲击疗法、复方新诺明)。接受根据病情阶段调整治疗的患者中,病情加重的发生率明显高于接受传统治疗的患者,而接受传统治疗的患者中致死率则高得多。